SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-04-003155
Filing Date
2004-03-11
Accepted
2004-03-11 08:55:39
Documents
12
Period of Report
2003-12-28

Document Format Files

Seq Description Document Type Size
1 JOHNSON & JOHNSON y94471e10vk.txt 10-K 60700
3 DOMESTIC DEFERRED COMPENSATION PLAN y94471exv10wg.txt EX-10.G 17474
4 EXECUTIVE INCOME DEFERRAL PLAN (AS AMENDED) y94471exv10wi.txt EX-10.I 26056
5 STATEMENT OF COMPUTATION OF RATIO OF EARNINGS y94471exv12.txt EX-12 3183
6 PAGES 28-62 OF 2003 ANNUAL REPORT TO SHAREHOLDERS y94471exv13.txt EX-13 215368
7 SUBSIDIARIES y94471exv21.txt EX-21 19201
8 CONSENT OF INDEPENDENT ACCOUNTANTS y94471exv23.txt EX-23 1222
9 CERTIFICATION OF CEO y94471exv31wa.txt EX-31.A 3655
10 CERTIFICATION OF CFO y94471exv31wb.txt EX-31.B 3657
11 CERTIFICATION OF CEO y94471exv32wa.txt EX-32.A 1531
12 CERTIFICATION OF CFO y94471exv32wb.txt EX-32.B 1533
13 CAUTIONARY STATEMENT y94471exv99wb.txt EX-99.B 7300
  Complete submission text file 0000950123-04-003155.txt   363731
Mailing Address
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 7325242454
JOHNSON & JOHNSON (Filer) CIK: 0000200406 (see all company filings)

IRS No.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 0103
Type: 10-K | Act: 34 | File No.: 001-03215 | Film No.: 04661765
SIC: 2834 Pharmaceutical Preparations